节点文献

12-脂氧合酶抑制剂黄芩素对2型糖尿病大鼠肾脏细胞外基质的影响及机制

Effect and Mechanism of Baicalein on Extracellular Matrix of Kidney in Type 2 Diabetic Rats

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 吴泽成刘慎微董骏武尹超

【Author】 WU Zecheng,LIU Shenwei,DONG Junwu,et al Department of Nephrology,Sanxia Central Hosipital,Chongqing(404000)

【机构】 重庆市三峡中心医院肾内科华中科技大学同济医学院附属同济医院肾内科湖北省武汉市第一人民医院肾内科

【摘要】 目的:探讨12-脂氧合酶(12-lipoxygenase,12-LO)特异性抑制剂黄芩素(baicalein,BAI)对2型糖尿病大鼠肾脏细胞外基质(ECM)的影响及机制。方法:将链脲佐菌素(streptozotocin,STZ)诱导的2型糖尿病大鼠随机分为:对照组、模型组、黄芩素低剂量治疗组(80 mg·kg-1·d-1)和高剂量治疗组(160 mg·kg-1·d-1)。治疗12周后检测各组大鼠尿白蛋白排泄率(UAER)、血糖(BG)、血肌酐(Scr)、血尿素氮(BUN)、内生肌酐清除率(Ccr)等变化;应用免疫组化技术检测各组肾组织中胶原Ⅳ(ColⅣ)、纤维连接蛋白(FN)、层黏连蛋白(LN)的表达;应用RT-PCR方法检测12-LO mRNA的表达。结果:治疗组较模型组明显改善尿白蛋白、BUN水平和肾脏肥大指数等。与对照组比较,模型组大鼠肾脏ColⅣ、FN、LN的表达明显增加;治疗组可明显降低糖尿病大鼠肾脏ColⅣ、FN、LN的表达。12-LO mRNA的相对含量模型组明显高于对照组(P<0.01);低、高剂量治疗组较模型组显著降低(P<0.01)。两治疗组之间各指标无统计学差异。结论:BAI对2型糖尿病大鼠肾脏具有明显的保护作用,其机制可能是通过抑制12-LO mRNA的表达,从而下调肾脏ColⅣ、FN、LN的表达,减少ECM沉积,延缓糖尿病肾病的发生、发展。

【Abstract】 Objective:To explore the effects of BAI on extracellular matrix of kidney and probable mechanism in type 2 diabetic rats.Methods:Streptozotocin induced diabetic rats were randomly assigned to four groups:control group,type 2 diabetic model group and BAI treated group s(80 mg·kg-1·d-1 or 160 mg·kg-1·d-1 respectively).After 12 weeks,the expression of ColⅣ,FN and LN in the renal tissue of type 2 diabetic rats was detected by immunohistochemistry.In addition,BG、Scr、BUN、Ccr and UAER were measured respectively.12-Lipoxygenase gene expression was studied with RT-PCR.Results:Compared to diabetic model group,the levels of UAER、Scr、BUN,kidney/weigh in BAI treated groups were significantly decreased,and the expressions of ColⅣ,FN and LN increased in the renal tissue of type 2 diabetic rats(P<0.01).BAI could significantly reduce the expression of ColⅣ,FN and LN in the renal tissue of diabetic rats(P<0.01).12-LO mRNA was significantly increased in the renal tissue of diabetic rats.The expression level of 12-LO mRNA was obviously down-regulated in BAI treated group.All indices in the two treatment groups have no significant difference.Conclusion:BAI can not decrease the blood sugar,by inhibiting the expression of 12-LO mRNA and down-regulating the expression of ColⅣ,FN and LN in renal tissue.It can significantly relieve ECM accumulation and it may be hopefully served as a useful strategy for prevention and treatment of diabetic nephropathy.

  • 【文献出处】 中国中西医结合肾病杂志 ,Chinese Journal of Integrated Traditional and Western Nephrology , 编辑部邮箱 ,2009年02期
  • 【分类号】R285.5
  • 【被引频次】18
  • 【下载频次】196
节点文献中: 

本文链接的文献网络图示:

本文的引文网络